1. Jiang, Dongzhen, Zhang, Huawei, Yin, Bingde, Lu, Xuwei, He, Chang. . The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway. In Combinatorial chemistry & high throughput screening, 27, 1984-1998. doi:10.2174/0113862073273633231113060429. https://pubmed.ncbi.nlm.nih.gov/38963027/
2. Jian, Weihua, Zhang, Lei. 2024. POLE2 silencing inhibits the progression of colorectal carcinoma cells via wnt signaling axis. In Cancer biology & therapy, 25, 2392339. doi:10.1080/15384047.2024.2392339. https://pubmed.ncbi.nlm.nih.gov/39155507/
3. Wang, Baichuan, Hu, Hongzhi, Wang, Xiaohui, Liu, Weijian, Wu, Qiang. 2024. POLE2 promotes osteosarcoma progression by enhancing the stability of CD44. In Cell death discovery, 10, 177. doi:10.1038/s41420-024-01875-x. https://pubmed.ncbi.nlm.nih.gov/38627379/
4. Sun, Ming-Yu, Wang, Lin, Shen, Zheng-Yu. 2023. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway. In Current medical science, 43, 1162-1172. doi:10.1007/s11596-023-2813-7. https://pubmed.ncbi.nlm.nih.gov/38079056/
5. Zhang, Chuanjie, Shen, Yan, Gao, Lili, Xu, Danfeng, He, Hongchao. 2021. Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1. In Frontiers in cell and developmental biology, 9, 622344. doi:10.3389/fcell.2021.622344. https://pubmed.ncbi.nlm.nih.gov/33644060/